Skip to content
★ Sign in to follow
高

高青平

Cadre Supérieur
泽璟制药
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€21k
▼ Sales (0 ops.)
—

Latest filing published 22 Mar 2022 for 泽璟制药, €10k.

Filing timeline

BuySale
高青平

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
0%
Median T+90
-1.7%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 22 Mar 2022 · 1692 days ago · €10k
    +34.9%
    Entry CN¥37.06 · Close at T+365 CN¥50.01
  • Filed 11 Mar 2022 · 1703 days ago · €10k
    +37.1%
    Entry CN¥36.45 · Close at T+365 CN¥49.97

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

高青平: trading record in brief

All filings by 高青平 on record concern 泽璟制药, in the capacity of senior executive. Between 11 March 2022 and 22 March 2022, the trades on record add up to 2 filings.

Purchases make up the whole of the open-market record (2 purchases, €21k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The newest entry dates from 22 March 2022: an open-market purchase of €10k, in 泽璟制药. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Companies and markets linked to 高青平

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    高级管理人员Executives泽璟制药
    73,400 CNY34SSE
    2,000 shares50.7% of flowA股XSHGSSE:173000005378610140
    Canonical exit: 20 Jun 2022 (T+90)
  • ▲
    高级管理人员Executives泽璟制药
    71,000 CNY34SSE
    2,000 shares49.3% of flowA股XSHGSSE:173000005358674400
    Canonical exit: 9 Jun 2022 (T+90)

2 of 2 declarations